Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail.
about
CCR5 monoclonal antibodies for HIV-1 therapyA phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavirTherapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach.The effect of single- and multiple-dose etravirine on a drug cocktail of representative cytochrome P450 probes and digoxin in healthy subjects.The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteers.Evaluation on activity of cytochrome p450 enzymes in turbot via a probe drug cocktail.
P2860
Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Evaluation of the drug interac ...... ed cooperstown 5 + 1 cocktail.
@en
type
label
Evaluation of the drug interac ...... ed cooperstown 5 + 1 cocktail.
@en
prefLabel
Evaluation of the drug interac ...... ed cooperstown 5 + 1 cocktail.
@en
P2093
P2860
P356
P1476
Evaluation of the drug interac ...... ed cooperstown 5 + 1 cocktail.
@en
P2093
Anne N Nafziger
Brendan M Johnson
Ivy H Song
Joseph S Bertino
Julie Borland
Kimberly K Adkison
M Michelle Berrey
Stephen C Piscitelli
P2860
P304
P356
10.1177/0091270006287291
P577
2006-05-01T00:00:00Z